Morphine suppresses peripheral responses and transforms brain myeloid gene expression to favor neuropathogenesis in

Howard S Fox1, Meng Niu2, Brenda M Morsey1

  • 1Departments of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE, United States.

Frontiers in Immunology
|December 5, 2022
PubMed

Insights

Morphine worsens simian immunodeficiency virus (SIV) infection in the brain by creating an immunosuppressive environment and promoting a neurodegenerative phenotype in microglia. This opioid-induced immune suppression is linked to increased viral reservoirs.

Area of Science:

  • Neuroscience
  • Immunology
  • Virology

Background:

  • Opioid abuse and HIV infection represent twin pandemics with severe physiological impacts, particularly on the brain.
  • Previous research indicated morphine increases the viral reservoir in SIV-infected macaques' brains.

Purpose of the Study:

  • To investigate the interaction between morphine and SIV to identify host-specific targets.
  • To understand how morphine affects the brain during SIV infection.

Main Methods:

  • A multimodal approach was used, examining systemic parameters and single-cell analysis of microglia and macrophages in the brain.
  • Assessed viral load, immune response, and gene expression profiles.

Main Results:

  • Morphine induced an immunosuppressive environment, blunting initial infection responses, which continued despite antiretroviral treatment.
  • Antiretroviral drug levels in cerebrospinal fluid and brain tissue remained unaffected by morphine.
  • Microglia and brain macrophages exhibited a transcriptional signature associated with neurodegeneration, with significantly elevated osteopontin expression in microglia, particularly in white matter.

Conclusions:

  • Morphine is detrimental to SIV/HIV infection, especially within the brain.
  • Elevated osteopontin in microglia is linked to HIV neuropathogenesis and viral reservoir maintenance.
  • Morphine's immunosuppressive effects and promotion of neurodegeneration exacerbate SIV/HIV brain pathology.

Related Concept Videos

Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
328
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
723
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.4K